Pharmacopeia
DEXMEDETOMIDINE
Core pharmacology
- Introduction
Central alpha2 agonist
Greater selectivity for A2 than clonidine- Chemical Pharmaceutics
D-stereoisomer
- Distribution
Lipid soluble (rapid distribution)
- Protein binding
95%
- Volume of distribution
2l/kg (steady state)
- Metabolism
Hepatic via CYP and glucuronidation
inactive metabolites- Half-life
Large variation in CSHT with infusion length (T1/2 5 minutes after 10 minutes IV, T1/2 240 minutes after 8 hour IV)
- Class Group
Highly selective alpha-2 adrenoceptor agonist sedative with sympatholytic properties.
- Indications Uses
Sedation of ventilated adult ICU patients and procedural sedation of non-intubated adults. Also used for awake fibreoptic intubation in selected patients.
- Presentation
Clear, colourless dexmedetomidine hydrochloride solution for intravenous use. Current Australian product information includes 200 micrograms in 2 mL vials.
- Mechanism of action
Specific alpha-2 agonist acting primarily in the locus coeruleus to increase conductance through K+ channels. 8 times more selective than clonidine. Acts on all 3 subtypes of alpha-2R (A, B, C)
- Adverse Effects Toxicity
- Transient hypertension (due to peripheral smooth muscle α2B agonism) -> reflex bradycardia Later, hypotension and bradycardia. Rebound HTN on ceasing dose - Dry mouth - nausea
- Absorption
Intravenous administration bypasses an absorption phase. For procedural sedation, clinically effective sedation after a loading infusion is typically seen within about 10-15 minutes.
- Excretion
Inactive metabolites Excreted in urine
- Physiological effects
Produces arousable sedation with minimal respiratory depression. Cardiovascular effects include bradycardia and hypotension, with transient hypertension possible during loading or higher exposure.
- Route And Dose
ICU sedation: maintenance infusion generally 0.2-1 microgram/kg/hour, titrated to the required level. A loading dose may be omitted when converting from another sedative. Procedural sedation: loading dose 1 microgram/kg over 10-20 minutes followed by 0.2-1 microgram/kg/hour, titrated to effect.